What is it?
Also known as a Klatskin tumor, this cancer arises where the bile ducts exit the liver and major vessels converge, requiring removal of the affected bile duct together with the adjoining liver lobe and careful reconstruction.
Who is this for?
- Hilar cholangiocarcinoma (Klatskin tumor)
- Carefully selected, less advanced tumors
- Cases requiring bile duct and adjoining liver lobe removal
- Tumors involving the portal vein or hepatic artery
How is the procedure performed?
- Magnified view and fine wristed instruments separate tumor from vessels
- Affected bile duct segment removed with the adjoining liver lobe
- Portion of portal vein or hepatic artery removed if involved
- Precise reconstruction reconnects remaining bile ducts to the intestine
What are the benefits?
Fine, wristed instruments suited to separating the tumor from major vessels at the hilum.
Supports the precise stitching needed to reconnect the bile ducts.
Reduced blood loss during one of hepatobiliary surgery's most demanding resections.
Outcomes broadly comparable to open surgery in carefully selected patients.
Potentially shorter recovery than traditional open resection.
Prioritizes margin-free tumor removal, the strongest predictor of long-term survival.
Available through specialized centers experienced in robotic hepatobiliary surgery.
Performed alongside careful planning to relieve jaundice safely before the main operation.
What should patients expect (risks & recovery)?
Surgery for hilar cholangiocarcinoma carries significant risks given its location near major vessels, and achieving a complete, margin-free removal remains the priority in every case, since this most influences long-term survival. Every patient undergoes detailed imaging, often including MRI and specialized bile duct imaging, to map the tumor and plan the safest approach, sometimes involving a combined hepatobiliary and transplant team. In some cases, procedures to relieve jaundice, such as a bile duct stent, are performed beforehand to make the eventual surgery safer. Because this cancer is uncommon and complex, thorough evaluation and honest discussion with patients begin from the very first consultation.
